Why is MTNB stock going down - MACD Histogram Reversal Alerts - mustnews.co.kr
2 days ago • Google News
Matinas BioPharma Holdings Inc (MTNB)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 5.75M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 8.38
52W Low
$ 0.47
Dividend Yield
0.00%
Beta
1.32
Technicals
50-Day MA
0.9232
200-Day MA
0.7881
52 Week High
8.385
52 Week Low
0.4748
About MTNB
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology.
Employees
3
Headquarters
Bedminster, NJ
CEO
Mr. Jerome D. Jabbour J.D.
Latest News
MTNB Enters Reversal Setup in Weekly Charts - Fast Exit and Entry Strategy Guide Offered - metal.it
2 weeks ago • Google News
Is MTNB stock a good hedge against inflation - Profitable Yet Secure Picks - beatles.ru
4 weeks ago • Google News